These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8705955)

  • 21. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.
    Perry PJ; Zeilmann C; Arndt S
    J Clin Psychopharmacol; 1994 Aug; 14(4):230-40. PubMed ID: 7962678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
    Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
    J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.
    Wilens TE; Biederman J; Baldessarini RJ; Geller B; Schleifer D; Spencer TJ; Birmaher B; Goldblatt A
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1491-501. PubMed ID: 8936916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives.
    Brown RP; Kocsis JH; Glick ID; Dhar AK
    J Clin Psychopharmacol; 1984 Dec; 4(6):311-5. PubMed ID: 6511997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
    Brown CS; Wells BG; Cold JA; Froemming JH; Self TH; Jabbour JT
    J Clin Psychopharmacol; 1990 Oct; 10(5):359-62. PubMed ID: 2258453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
    Marshall JB; Forker AD
    Am Heart J; 1982 Mar; 103(3):401-14. PubMed ID: 7039280
    [No Abstract]   [Full Text] [Related]  

  • 28. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract]   [Full Text] [Related]  

  • 29. The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder.
    Himpel S; Banaschewski T; Heise CA; Rothenberger A
    Expert Opin Drug Saf; 2005 Mar; 4(2):311-21. PubMed ID: 15794722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients.
    Schenk PW; van Fessem MA; Verploegh-Van Rij S; Mathot RA; van Gelder T; Vulto AG; van Vliet M; Lindemans J; Bruijn JA; van Schaik RH
    Mol Psychiatry; 2008 Jun; 13(6):597-605. PubMed ID: 17667959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [ECG changes after paroxetine. 3 case reports].
    Erfurth A; Loew M; Dobmeier P; Wendler G
    Nervenarzt; 1998 Jul; 69(7):629-31. PubMed ID: 9715482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial electrocardiogram changes in acute tricyclic antidepressant overdoses.
    Liebelt EL; Ulrich A; Francis PD; Woolf A
    Crit Care Med; 1997 Oct; 25(10):1721-6. PubMed ID: 9377889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden death of a child treated with imipramine. Case study.
    Varley CK
    J Child Adolesc Psychopharmacol; 2000; 10(4):321-5. PubMed ID: 11191693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of desipramine.
    Werry JS
    J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):588-91. PubMed ID: 8005913
    [No Abstract]   [Full Text] [Related]  

  • 36. Growth deficits and desipramine.
    Holt KG
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1167-8. PubMed ID: 1429424
    [No Abstract]   [Full Text] [Related]  

  • 37. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tricyclic antidepressants dosage and depressed elderly inpatients: a retrospective pharmaco-epidemiologic study].
    Ballon N; Siobud-Dorocant E; Even C; Slama F; Dardennes R
    Encephale; 2001; 27(4):373-6. PubMed ID: 11686060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of desipramine on autonomic control of the heart.
    Walsh BT; Giardina EG; Sloan RP; Greenhill L; Goldfein J
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):191-7. PubMed ID: 8150790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricyclic antidepressants and cardiac patients with pacemakers.
    Alexopoulos GS; Shamoian CA
    Am J Psychiatry; 1982 Apr; 139(4):519-20. PubMed ID: 7065303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.